Ireland - English - HPRA (Health Products Regulatory Authority)

schering-plough limited - homatropine - eye drops solution - 1 %w/v

Ireland - English - HPRA (Health Products Regulatory Authority)

schering-plough limited - homatropine - eye drops solution - 2 %w/v

United States - English - NLM (National Library of Medicine)

atlantic biologicals corps - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), homatropine methylbromide (unii: 68jrs2hc1c) (methylhomatropine - unii:p97ogj7l1l) - hydrocodone bitartrate 5 mg in 5 ml - hydrocodone bitartrate and homatropine methylbromide syrup is indicated for the symptomatic relief of cough. hydrocodone bitartrate and homatropine methylbromide syrup should not be administered to patients who are hypersensitive to hydrocodone or homatropine methylbromide. hydrocodone bitartrate and homatropine methylbromide syrup is a schedule ii narcotic. psychic dependence, physical dependence and tolerance may develop upon repeated administration of narcotics; therefore, hydrocodone bitartrate and homatropine methylbromide should be prescribed and administered with caution. however, psychic dependence is unlikely to develop when hydrocodone bitartrate and homatropine methylbromide is used for a short time for the treatment of cough. physical dependence, the condition in which continued administration of the drug is required to prevent the appearance of a withdrawal syndrome, assumes clinically significant proportions only after several weeks of continued oral narcotic use, although some mild degree of ph

United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7) - hydrocodone bitartrate 5 mg in 5 ml - hydrocodone bitartrate and homatropine methylbromide oral solution is indicated for the symptomatic relief of cough in patients 18 years of age and older. important limitations of use : hydrocodone bitartrate and homatropine methylbromide oral solution is contraindicated for: hydrocodone bitartrate and homatropine methylbromide oral solution is also contraindicated in patients with: risk summary hydrocodone bitartrate and homatropine methylbromide oral solution is not recommended for use in pregnant women, including during or immediately prior to labor. prolonged use of opioids during pregnancy may cause neonatal opioid withdrawal syndrome [see warnings and precautions (5.13), clinical considerations ]. there are no available data with hydrocodone bitartrate and homatropine methylbromide oral solution use in pregnant women to inform a drug-associated risk for adverse developmental outcomes. published studies with hydrocodone have reported inconsistent findings and have important methodological limitations (s

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - homatropine methylbromide (unii: 68jrs2hc1c) (methylhomatropine - unii:p97ogj7l1l) -

United States - English - NLM (National Library of Medicine)

genus lifesciences inc. - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), homatropine methylbromide (unii: 68jrs2hc1c) (methylhomatropine - unii:p97ogj7l1l) - hycodan is indicated for the symptomatic relief of cough in adult patients 18 years of age and older. limitations of use: - not indicated for pediatric patients under 18 years of age [see use in specific populations (8.4)] . - contraindicated in pediatric patients less than 6 years of age [see contraindications (4)] . - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1)], reserve hycodan for use in adult patients for whom the benefits of cough suppression are expected to outweigh the risks, and in whom an adequate assessment of the etiology of the cough has been made. hycodan is contraindicated for: - all pediatric patients younger than 6 years of age [see warnings and precautions (5.2, 5.3), use in specific populations (8.4)] . - significant respiratory depression [see warnings and precautions (5.2)] . - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings and precau

Ireland - English - HPRA (Health Products Regulatory Authority)

alcon laboratories (uk) ltd - homatropine -

India - English - Central Drugs Standard Control Organization

bell ph. - homatropine - f. dps - 2% - 10 ml

India - English - Central Drugs Standard Control Organization

bell ph. - homatropine - eye dps - 1% - 5ml

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

homatropine hydrochloride 20mg